Fluvoxamine Resources

S&C Related Contents
Celexa (citalopram) - Celexa, Cipramil, Emocal, Sepram, Seropram
Fluvoxamine - Luvox, Faverin
Lexapro (escitalopram) - Lexapro, Cipralex, Esertia
Paxil (paroxetine) - Paxil, Seroxat, Aropax, Deroxat, Rexetin, Xetanor, Paroxat
Prozac (fluoxetine) - Prozac, Fontex, Seromex, Seronil, Sarafem, Fluctin (EUR))
Symbyax (olanzepine/fluoxetine)
Zoloft (sertraline) - Zoloft, Lustral, Serlain
Other SSRI Birth Defect Articles
Congenital Heart Defects - Atrial and Ventricular Septal Defects
Persistent Pulmonary Hypertension of the Newborn (PPHN)
Omphalocele - Abdominal Birth Defects
Craniosynostosis - Cranial Birth Defects
Paxil Suicide, Self-Mutilation and Harm
Additional Contents
SSRI antidepressants including the popular drug Fluvoxamine (Luvox, Faverin Symbax) have been linked to variety of severe birth defects including Persistent Pulmonary Hypertension (PPHN), heart, lung, abdominal and cranial defects.
If you or a loved one have taken Fluvoxamine, Luvox, Faverin or Symbax while pregnant and given birth to a child with a congenital birth defect, you should contact us immediately. You may be entitled to compensation and we can help.
The U.S. Food & Drug Administration has warned doctors and patients that exposure to SSRI's such as Fluvoxamine during pregnancy pose a serious risk to the fetus and has been linked to an increased risk of Congenital Heart Defects.
More specifically, the most common form of Fluvoxamine induced heart birth defects observed by our firm has been either Atrial Septal Defects or Ventricular Septal Defects.
Recently, The New England Journal of Medicine released the results of a case-controlled study wherein SSRI's including Fluvoxamine were linked to an increased risk of an infant being born with Persistent Pulmonary Hypertension of the Newborn (PPHN).
Shortly after the aforementioned study was released, the FDA issued another Public Health Advisory warning that exposure to Fluvoxamine during pregnancy posed a serious risk to the fetus and was linked to an increased risk of PPHN.
According to information released from the National Birth Defects Prevention Study of Infants, SSRI antidepressants like Fluvoxamine may cause two separate congenital abnormalities called Omphalocele and Craniosynostosis.
Omphalocele is a congenital (present at birth) abdominal wall defect at the base of the umbilical cord (umbilicus); the infant is born with a sac protruding through the defect which contains small intestine, liver, and large intestine.
Craniosynostosis is a congenital (present at birth) defect that causes one or more sutures on a baby's head to close earlier than normal. Sutures are connections that separate each individual skull bones. The early closing of a suture leads to an abnormally shaped head.
The Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus exclusively on the representation of plaintiffs in Fluvoxamine lawsuits. We are handling individual litigation nationwide and currently accepting new Fluvoxamine birth defect cases in all 50 states.
Attention Attorneys: We do not publish prior verdict/settlements. If you are an attorney and would like to refer us a case or for us to send you a profile of prior award judgments or average referral fees, please visit the attorney referral section of our website.
Free Confidential Case Evaluation
Toll Free 24 hrs/day (866) 588-0600
Secure 128-bit SSL Encrypted Email Communication - Click Here.
Secure 1024-bit SSL Encrypted Live Chat Communication - Click Here.
= Required Field